Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
May 23, 2023
0Patent Application Number
167660430
Date Filed
November 21, 2018
0Patent Citations
0
0
0
0
...
Patent Citations Received
Patent Primary Examiner
CPC Code
The present invention relates to the design of a customized therapy for a subject with breast cancer based on the c-MAF expression level and the menopausal status of the subject. In some embodiments, the customized therapy comprises an agent for avoiding, treating or preventing bone degradation. In some embodiments, the agent for avoiding, treating or preventing bone degradation is zoledronic acid. In other embodiments, the agent is clodronate or denosumab.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
